Compare GCO & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GCO | DNA |
|---|---|---|
| Founded | 1924 | 2008 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.0M | 497.8M |
| IPO Year | 1994 | N/A |
| Metric | GCO | DNA |
|---|---|---|
| Price | $38.42 | $7.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $33.00 | $8.50 |
| AVG Volume (30 Days) | 137.7K | ★ 884.4K |
| Earning Date | 06-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,606,898,000.00 | N/A |
| Revenue This Year | $0.78 | N/A |
| Revenue Next Year | $2.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.71 | N/A |
| 52 Week Low | $21.93 | $5.37 |
| 52 Week High | $43.60 | $17.58 |
| Indicator | GCO | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 49.61 |
| Support Level | $31.11 | $7.37 |
| Resistance Level | $38.72 | $10.27 |
| Average True Range (ATR) | 1.48 | 0.52 |
| MACD | 0.24 | 0.14 |
| Stochastic Oscillator | 67.48 | 52.67 |
Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.